Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models

• Main Authors: Jang Woo Park (Author), Yunan Tian (Author), Sang-Tae Kim (Author), Chanwoo Park (Author), Yu Mi Kim (Author), Hye Kyung Chung (Author), Kyeong Min Kim (Author), Geon-Ho Jahng (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundOligomeric amyloid beta (oAβ) is a toxic factor that acts in the early stage of Alzheimer's disease (AD) and may initiate the pathologic cascade. Therefore, detecting oAβ has a crucial role in the early diagnosis, monitoring, and treatment of AD.PurposeThe purpose of this study was to...